In today's Just The Facts...
Orthocell Ltd (ASX:OCC)
Orthocell has delivered its sixth consecutive record quarter, posting $3 million in revenue for September — up 11% from June — driven by strong Remplir sales in Australia and Singapore. The company now holds $27 million in cash, with U.S. commercialisation tracking ahead of schedule.
Alkane Resources Ltd (ASX:ALK)
Alkane Resources produced over 36,000 gold-equivalent ounces in the September quarter, supported by three operating mines following the Mandalay merger. The company ended the period with a solid $191 million in cash and investments, even after repaying $45 million in debt.
Prescient Therapeutics (ASX:PTX)
Prescient Therapeutics closed the quarter with $12.3 million in cash after completing a $9.8 million raise. The company continues to advance its Phase 2a cancer trial and recently shared promising new data, with spending remaining in line with budget.
#Orthocell #AlkaneResources #PrescientTherapeutics #ASX